Phase II study of FOLFIRINOX for chemotherapy‐naive Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka… - Cancer …, 2014 - Wiley Online Library
The FOLFIRINOX combination of chemotherapy drugs had not been fully evaluated for
Japanese pancreatic cancer patients. Therefore, we carried out a phase II study to examine …

[PDF][PDF] Phase II study of FOLFIRINOX for chemotherapy-naıve Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka, J Furuse… - Cancer Sci, 2014 - cyberleninka.org
Materials and Methods Patients. The inclusion criteria were: histologically or cytologically
confirmed pancreatic adenocarcinoma or adenosquamous carcinoma; an Eastern …

Phase II study of FOLFIRINOX for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka, J Furuse… - Cancer Science, 2014 - cir.nii.ac.jp
抄録< jats: p> The< jats: styled-content style=" fixed-case"> FOLFIRINOX</jats: styled-
content> combination of chemotherapy drugs had not been fully evaluated for Japanese …

[HTML][HTML] Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka, J Furuse… - Cancer …, 2014 - ncbi.nlm.nih.gov
The FOLFIRINOX combination of chemotherapy drugs had not been fully evaluated for
Japanese pancreatic cancer patients. Therefore, we carried out a phase II study to examine …

[引用][C] Phase II study of FOLFIRINOX for chemotherapy-naethve Japanese patients with metastatic pancreatic cancer

T OKUSAKA, M IKEDA, A FUKUTOMI, T IOKA… - Cancer Science …, 2014 - jglobal.jst.go.jp
Phase II study of FOLFIRINOX for chemotherapy-naethve Japanese patients with metastatic
pancreatic cancer | Article Information | J-GLOBAL Art J-GLOBAL ID:201402222964349627 …

Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka, J Furuse… - Cancer …, 2014 - hero.epa.gov
The FOLFIRINOX combination of chemotherapy drugs had not been fully evaluated for
Japanese pancreatic cancer patients. Therefore, we carried out a phase II study to examine …

[PDF][PDF] Phase II study of FOLFIRINOX for chemotherapy-naıve Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka, J Furuse… - Cancer Sci, 2014 - researchgate.net
Materials and Methods Patients. The inclusion criteria were: histologically or cytologically
confirmed pancreatic adenocarcinoma or adenosquamous carcinoma; an Eastern …

Phase II study of FOLFIRINOX for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka… - Cancer …, 2014 - search.proquest.com
The FOLFIRINOX combination of chemotherapy drugs had not been fully evaluated for
Japanese pancreatic cancer patients. Therefore, we carried out a phase II study to examine …

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

T Okusaka, M Ikeda, A Fukutomi, T Ioka… - Cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
The FOLFIRINOX combination of chemotherapy drugs had not been fully evaluated for
Japanese pancreatic cancer patients. Therefore, we carried out a phase II study to examine …

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.

T Okusaka, M Ikeda, A Fukutomi, T Ioka, J Furuse… - Cancer …, 2014 - europepmc.org
The FOLFIRINOX combination of chemotherapy drugs had not been fully evaluated for
Japanese pancreatic cancer patients. Therefore, we carried out a phase II study to examine …